Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
about
Applications of Fourier Transform Ion Cyclotron Resonance (FT-ICR) and Orbitrap Based High Resolution Mass Spectrometry in Metabolomics and LipidomicsPostpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshopDetecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data.The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome.A Method for In-Depth Structural Annotation of Human Serum Glycans That Yields Biological VariationsThe application of SELDI-TOF-MS in clinical diagnosis of cancersAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.The glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery.Liquid chromatography-selected reaction monitoring (LC-SRM) approach for the separation and quantitation of sialylated N-glycans linkage isomers.Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.Characterization of novel O-glycans isolated from tear and saliva of ocular rosacea patients.Protein analysis by shotgun/bottom-up proteomicsComparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis.A comprehensive compositional analysis of heparin/heparan sulfate-derived disaccharides from human serum.Serum glycan signatures of gastric cancer.The immunomodulating roles of glycoproteins in epithelial ovarian cancer.N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers.Isomeric complexity of glycosylation documented by MSn.Integrated mass spectrometry-based analysis of plasma glycoproteins and their glycan modifications.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Automated glycopeptide analysis--review of current state and future directionsSolid-phase glycan isolation for glycomics analysisGlycomics and disease markers.Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Application of nano-LC-based glycomics towards biomarker discovery.Hepatocellular carcinoma markers in the omics era: the glycomic analysisIsomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer.Precise structural analysis of O-linked oligosaccharides in human serum.Clinical glycomics for the diagnosis of congenital disorders of glycosylation.
P2860
Q26745581-33DED53F-84DF-4C54-8E32-87A6F11E9D8EQ26823516-27476057-19B8-4829-B203-68973A985F5AQ33392137-215468DE-2BC6-42B5-A911-CF253D8BC5D0Q33447457-E0D95410-6BFC-4C47-B351-23C3F3CB4036Q33728755-05B01E46-12EE-4F0C-A25D-CDBEFA057A87Q33936575-10AE39C5-17D4-4149-B8FE-3468D4CDA400Q33995843-1429B47A-D633-4193-B0AC-CF578D537504Q34383959-EC7AC70F-5100-4CD9-BE46-E7475D032856Q34464308-FAA560F6-3E0B-4C21-884F-260FD7F18E43Q34503577-7F312000-211A-4490-A1B8-4BF372DFAA69Q34537946-BEC6C124-53A6-4A21-8EBD-BB89855D11C0Q34600986-D36DB6F9-1B38-4EA9-9E33-95B3F223A19EQ34975642-03E60113-6875-44DA-888F-9F42FC8B9215Q34981189-A9D78DC6-1373-4235-A738-F4296279FBC8Q35064779-C1EBCDD6-B475-42D5-B1D5-DAF58792A4E9Q35077893-DBF2636A-480A-4C56-9529-804379871804Q35874750-30F1486D-00FA-4B77-8419-BE9DCF517BCBQ35902976-7A380F8A-45C4-43DC-9B2C-BB9E5A32873AQ36186390-D2FEF724-8993-4910-949E-896CA6EC79F3Q36368396-4A1F7278-6510-47CC-B11D-E5278242230FQ36582422-223FE01F-B597-459D-B4B4-D81E8E571D6DQ36860100-DCEF5B91-31F0-4640-A035-635ECCF043AAQ36908318-37785478-56C5-4822-A543-1B1C9F9E50C2Q37457130-DECE4BFF-4A4F-42A5-BAED-9CE908EE9855Q37484011-460298C5-FAD0-429E-AC67-871B59FCF453Q37961971-391581C4-E108-4509-9905-C91D0190781DQ39062915-DE33189D-4B14-4482-8C25-1B0359D310BEQ42279918-380F4070-315F-45CE-A32C-65B8279837A4Q54367528-08E1436F-983F-4093-BA64-8B3EA19458CDQ54959588-CE87EEEB-0225-42EF-9393-64B616976013
P2860
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
@ast
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
@en
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
@nl
type
label
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
@ast
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
@en
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
@nl
prefLabel
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
@ast
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
@en
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
@nl
P2093
P2860
P1476
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
@en
P2093
C Lebrilla
G S Leiserowitz
S Miyamoto
P2860
P304
P356
10.1111/J.1525-1438.2007.01028.X
P50
P577
2007-07-26T00:00:00Z